ACA
GYRE icon

Avoro Capital Advisors’s Gyre Therapeutics GYRE Stock Holding History

Avoro Capital Advisors’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-136,550
Closed -$26.4M – 51
2018
Q1 		$26.4M Buy
136,550
+83,217
+156% +$15.5M 1.27% 24
2017
Q4 		$5.46M Buy
+53,333
New +$2.72M 0.36% 35
2016
Q2 		– Sell
-636
Closed -$120K – 43
2016
Q1 		$120K Hold
636
– – 0.04% 35
2015
Q4 		$224K Sell
636
-110
-15% -$43.3K 0.08% 29
2015
Q3 		$391K Hold
746
– – 0.1% 31
2015
Q2 		$1.64M Buy
746
+154
+26% +$309K 0.45% 29
2015
Q1 		$1.39M Buy
+592
New +$1.22M 0.53% 31

Other funds holding GYRE

ACP
Acuta Capital Partners Redwood City, California $141M AUM 783.79% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
GTC
Ghost Tree Capital New York $276M AUM 70.11% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return